CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance

Chemokines and their receptors play important roles in the pathophysiology of many diseases by regulating the cellular migration of major inflammatory and immune players. The CXC motif chemokine subfamily is the second largest family, and it is further subdivided into ELR motif CXC (ELR+) and non-EL...

Full description

Saved in:
Bibliographic Details
Main Authors: Kayode Komolafe, Maricica Pacurari
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/4558159
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555215971155968
author Kayode Komolafe
Maricica Pacurari
author_facet Kayode Komolafe
Maricica Pacurari
author_sort Kayode Komolafe
collection DOAJ
description Chemokines and their receptors play important roles in the pathophysiology of many diseases by regulating the cellular migration of major inflammatory and immune players. The CXC motif chemokine subfamily is the second largest family, and it is further subdivided into ELR motif CXC (ELR+) and non-ELR motif (ELR-) CXC chemokines, which are effective chemoattractants for neutrophils and lymphocytes/monocytes, respectively. These chemokines and their receptors are expected to have a significant impact on a wide range of lung diseases, many of which have inflammatory or immunological underpinnings. As a result, manipulations of this subfamily of chemokines and their receptors using small molecular agents and other means have been explored for potential therapeutic benefit in the setting of several lung pathologies. Furthermore, encouraging preclinical data has necessitated the progression of a few of these drugs into clinical trials in order to make the most effective use of interventions in the development of viable targeted therapeutics. The current review presents the understanding of the roles of CXC ligands (CXCLs) and their cognate receptors (CXCRs) in the pathogenesis of several lung diseases such as allergic rhinitis, COPD, lung fibrosis, lung cancer, pneumonia, and tuberculosis. The potential therapeutic benefits of pharmacological or other CXCL/CXCR axis manipulations are also discussed.
format Article
id doaj-art-fb38080bbcf748a6a7a2bc37f01ecd37
institution Kabale University
issn 2042-0099
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Inflammation
spelling doaj-art-fb38080bbcf748a6a7a2bc37f01ecd372025-02-03T05:49:19ZengWileyInternational Journal of Inflammation2042-00992022-01-01202210.1155/2022/4558159CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological RelevanceKayode Komolafe0Maricica Pacurari1RCMI Center for Health Disparities ResearchRCMI Center for Health Disparities ResearchChemokines and their receptors play important roles in the pathophysiology of many diseases by regulating the cellular migration of major inflammatory and immune players. The CXC motif chemokine subfamily is the second largest family, and it is further subdivided into ELR motif CXC (ELR+) and non-ELR motif (ELR-) CXC chemokines, which are effective chemoattractants for neutrophils and lymphocytes/monocytes, respectively. These chemokines and their receptors are expected to have a significant impact on a wide range of lung diseases, many of which have inflammatory or immunological underpinnings. As a result, manipulations of this subfamily of chemokines and their receptors using small molecular agents and other means have been explored for potential therapeutic benefit in the setting of several lung pathologies. Furthermore, encouraging preclinical data has necessitated the progression of a few of these drugs into clinical trials in order to make the most effective use of interventions in the development of viable targeted therapeutics. The current review presents the understanding of the roles of CXC ligands (CXCLs) and their cognate receptors (CXCRs) in the pathogenesis of several lung diseases such as allergic rhinitis, COPD, lung fibrosis, lung cancer, pneumonia, and tuberculosis. The potential therapeutic benefits of pharmacological or other CXCL/CXCR axis manipulations are also discussed.http://dx.doi.org/10.1155/2022/4558159
spellingShingle Kayode Komolafe
Maricica Pacurari
CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
International Journal of Inflammation
title CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
title_full CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
title_fullStr CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
title_full_unstemmed CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
title_short CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
title_sort cxc chemokines in the pathogenesis of pulmonary disease and pharmacological relevance
url http://dx.doi.org/10.1155/2022/4558159
work_keys_str_mv AT kayodekomolafe cxcchemokinesinthepathogenesisofpulmonarydiseaseandpharmacologicalrelevance
AT maricicapacurari cxcchemokinesinthepathogenesisofpulmonarydiseaseandpharmacologicalrelevance